Evidence map›Paper›PMID 29961191›Full record

ArticleThe journal of physiological sciences : JPS2019

Mst1 promotes cardiac ischemia-reperfusion injury by inhibiting the ERK-CREB pathway and repressing FUNDC1-mediated mitophagy.

Wancheng Yu, Mei Xu, Tao Zhang, Qian Zhang, Chengwei Zou

Open access · goldAbstract read
In one paragraph

Article in The journal of physiological sciences : JPS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 120 citations in OpenAlex.

  1. Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. N6-methyladenosine readerWorld journal of gastroenterology · 2025
    Article
  7. Autophagy: a double-edged sword in ischemia-reperfusion injury.Cellular & molecular biology letters · 2025
    Review
  8. Review
  9. Autophagy · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Circular RNAs: a small piece in the heart failure puzzle.Functional & integrative genomics · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Mitophagy for cardioprotection.Basic research in cardiology · 2023
    Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Wancheng YuDepartment of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong University, NO. 324 Jingwu Road, Jinan, 250021, Shandong, China.
Mei XuDepartment of Geriatrics, Shandong University Qilu Hospital, 107 Wenhua Xi Road, Jinan, 250021, Shandong, China.
Tao ZhangDepartment of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong University, NO. 324 Jingwu Road, Jinan, 250021, Shandong, China.
Qian ZhangDepartment of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong University, NO. 324 Jingwu Road, Jinan, 250021, Shandong, China.
Chengwei ZouDepartment of Cardiovascular Surgery, Shandong Provincial Hospital Affiliated to Shandong University, NO. 324 Jingwu Road, Jinan, 250021, Shandong, China. chengweizou163@hotmail.com.
Shandong Provincial Hospital · CNShandong University · CNQilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac ischemia-reperfusion (I/R) injury results mainly from mitochondrial dysfunction and cardiomyocyte death. Mitophagy sustains mitochondrial function and exerts a pro-survival effect on the reperfused heart tissue. Mammalian STE20-like kinase 1 (Mst1) regulates chronic cardiac metabolic damage and autophagic activity, but its role in acute cardiac I/R injury, especially its effect on mitophagy, is unknown. The aim of this study is to explore whether Mst1 is involved in reperfusion-mediated cardiomyocyte death via modulation of FUN14 domain containing 1 (FUNDC1)-related mitophagy. Our data indicated that Mst1 was markedly increased in reperfused hearts. However, genetic ablation of Mst1 in Mst1-knockout (Mst1-KO) mice significantly reduced the expansion of the cardiac infarction area, maintained myocardial function and abolished I/R-mediated cardiomyocyte death. At the molecular level, upregulation of Mst1 promoted ROS production, reduced mitochondrial membrane potential, facilitated the leakage of mitochondrial pro-apoptotic factors into the nucleus, and activated the caspase-9-related apoptotic pathway in reperfused cardiomyocytes. Mechanistically, Mst1 activation repressed FUNDC1 expression and consequently inhibited mitophagy. However, deletion of Mst1 was able to reverse FUNDC1 expression and thus re-activate protective mitophagy, effectively sustaining mitochondrial homeostasis and blocking mitochondrial apoptosis in reperfused cardiomyocytes. Finally, we demonstrated that Mst1 regulated FUNDC1 expression via the MAPK/ERK-CREB pathway. Inhibition of the MAPK/ERK-CREB pathway prevented FUNDC1 activation caused by Mst1 deletion. Altogether, our data confirm that Mst1 deficiency sends a pro-survival signal for the reperfused heart by reversing FUNDC1-related mitophagy and thus reducing cardiomyocyte mitochondrial apoptosis, which identifies Mst1 as a novel regulator for cardiac reperfusion injury via modulation of mitochondrial homeostasis.

Indexed as

AnimalsCyclic AMP Response Element-Binding ProteinHippo KinasesMAP Kinase Signaling SystemMembrane ProteinsMiceMice, KnockoutMitochondriaMitochondrial ProteinsMitophagyMyocardial Reperfusion InjuryMyocytes, CardiacProtein Serine-Threonine KinasesCyclic AMP Response Element-Binding ProteinFUNDC1 protein, mouseHippo KinasesMembrane ProteinsMitochondrial ProteinsProtein Serine-Threonine KinasesStk4 protein, mouseCardiac I/R injuryERK-CREB signaling pathwayFUNDC1Mitochondrial apoptosisMst1

Identifiers

PMID29961191
PMCPMC10717665
OpenAlexW2809873157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.